Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Breast × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2587 Triple Negative Breast Neoplasms 417 Ovarian Neoplasms 178 Carcinoma, Non-Small-Cell Lung 166 Colorectal Neoplasms 159 Prostatic Neoplasms 156 Neoplasms 151 Lung Neoplasms 142 Neoplasm Metastasis 136 Melanoma 98 Pancreatic Neoplasms 96 Stomach Neoplasms 95 Endometrial Neoplasms 95 Uterine Cervical Neoplasms 76 Squamous Cell Carcinoma of Head and Neck 74 Colonic Neoplasms 71 Head and Neck Neoplasms 69 Carcinoma, Intraductal, Noninfiltrating 61 Urinary Bladder Neoplasms 57 Sarcoma 57 Motor Activity 50 Esophageal Neoplasms 50 Breast Carcinoma In Situ 50 Carcinoma, Renal Cell 48 Brain Neoplasms 45 Breast Cancer Female 36 Lymphedema 34 HER2-positive Breast Cancer 34 Advanced Breast Cancer 31 Small Cell Lung Carcinoma 30

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡